Navigation Links
BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery & Development of Innovative Therapeutics World Congress
Date:4/17/2008

SAN FRANCISCO, April 17 /PRNewswire/ -- BioSpace, the world's leading online bioscience job board community and life science career fair company, announced today an alliance with IBC Life Sciences whereby BioSpace will produce a Life Science Career Fair in conjunction with IBC's Drug Discovery & Development of Innovative Therapeutics World Congress (DDT) in Boston during August of 2008.

The event will be marketed and promoted to the 500,000 life science professionals from the BioSpace community as well as thousands of IBC conference attendees. For admittance to the Career Fair, all candidates are required to possess a four year degree in a relevant discipline, and a minimum of two years experience in a bioscience-related field or industry. As with every Career Fair, BioSpace will pre-screen all candidates. All companies exhibiting at the job fair will have access to a private, searchable BioSpace Resume Database containing the resumes of all candidates that register for the event.

"We are pleased to present a BioSpace Career Fair as part of the 2008 Drug Discovery & Development of Innovative Therapeutics (DDT) World Congress," said Wes Crews, CEO of BioSpace. "The BioSpace and DDT audiences dovetail nicely and present exhibitors of each event the opportunity to leverage the co-marketing efforts and foot traffic that we each present."

"IBC is proud to present the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress, and BioSpace is a natural fit for a Career Fair partner," said Michael Keenan, Director of Product Management for IBC Life Sciences. "We know that our complementary events will help to drive traffic to one another and anticipate a record turnout this year."

For more information about exhibiting at or attending the BioSpace Career Fair at Drug Discovery & Development of Innovative Therapeutics, please visit '/>"/>

SOURCE BioSpace
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioSpace to Host Regeneron Pharmaceuticals Career Fair in Whippany, New Jersey
2. Boehringer Ingelheim and BioSpace Search for Scientists at Career Fair in Boston, Massachusetts
3. BioSpace to Host Life Science Career Fair in Pennsylvania
4. BioSpace Boston Career Fair Attracts over 900 Bioscience Candidates
5. BioSpace.com Receives WEDDLEs 2008 Users Choice Award for Best Job Boards
6. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
7. BioSpace New Jersey Career Fair Attracts Over 1,000 Bioscience Candidates
8. BioSpace Career Fair in San Francisco Welcomes Over 1,000 Bioscience Professionals
9. BioSpace Career Fair in San Diego Draws Record Number of Bioscience Candidates
10. BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown(TM) Hotbed Campaign
11. BioSpace Launches 3rd Edition of BioForest(TM) Bioscience Marketing Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 China Biologic ... "Company"), a leading fully integrated plasma-based biopharmaceutical company ... that its majority-owned subsidiary, Shandong Taibang Biological Products ... certification from the China Food and Drug Administration ... facility. As previously disclosed in the Company,s public ...
(Date:12/24/2014)... SARASOTA, Fla. , Dec. 23, 2014  Rock ... today that it has filed a Clinical Trial Application ... Medicines Healthcare products Regulatory Agency (MHRA) seeking regulatory approval ... its lead molecule, Anatabine Citrate. Contingent on ... to conduct a Phase I trial to assess the ...
(Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
(Date:12/22/2014)... 22, 2014 The American ... of original research, reviews and editorials addressing developments ... practice, today published a provocative article exploring the ... progression and potential treatment of prostate cancer. ... and proposes the possibility that there could be ...
Breaking Biology Technology:China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... ( http://www.trimarkpublications.com ), a global leader in the biotechnology, ... published Regenerative Medicine Markets report that the ... billion in 2010 and is expected to reach $4.5 ... treat injuries and diseases with specially-grown tissues by way ...
... Sept. 1 UOP LLC, a Honeywell (NYSE: ... was selected for use in Rentech, Inc.,s Rialto Renewable ... fuels. The renewable energy center, to be ... yard and tree trimmings, into renewable, ultra-clean diesel fuel ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ... ended September 30, 2010 of approximately $86 million, as ... third quarter of 2009, a 20 percent year-over-year increase. ... 2010 sales of Avastin®, Herceptin®, Lucentis® and Tysabri® for ...
Cached Biology Technology:Regenerative Medicine Market Expected to Reach $4.5 Billion by 2014 2Honeywell UOP Technology Selected to Support Conversion of Biomass to Fuel at California Renewable Energy Facility 2Honeywell UOP Technology Selected to Support Conversion of Biomass to Fuel at California Renewable Energy Facility 3PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech 2PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech 3PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech 4PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech 5
(Date:12/17/2014)... 15, 2014 The Defense Logistics Agency ... to detect and prevent counterfeit microcircuits from entering ... agency started performing an in-house microcircuit anti-counterfeit initiative ... authenticity of purchased microcircuits while increasing their reliability ... measures will be conducted at DLA,s Electronics Product ...
(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a ... while. Hypertension – the medical term for high blood pressure ... 1800s, and the inflatable cuff that,s used in measuring blood ... mean there,s nothing new about hypertension, its triggers and its ... about the condition and the best ways to treat it. ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... in vitro fertilization offers couples the best chance for ... cause doctors to misdiagnose a small fraction of them, ... about the accuracy of preimplantation genetic diagnosis, the method ... IVF, UF researchers set out to study the procedure. ...
... at the University of Rochester Medical Center have discovered a ... harm the function of T-cells, which regulate the body's immune ... adds insight to the latest trend in lead research, as ... to understanding the long-term burden on the body, said Michael ...
... a small vertebra at a construction site near Dallas 17 ... the fossil record. Scientists now know the significance of Turner's ... with an evolutionary twist: a land-dwelling species that became fully ... Dallas Museum of Natural History, but it took several years ...
Cached Biology News:Genetic testing still smart choice, despite uncertainties 2Genetic testing still smart choice, despite uncertainties 3The dangerous legacy of lead 2Missing fossil link 'Dallasaurus' found 2Missing fossil link 'Dallasaurus' found 3Missing fossil link 'Dallasaurus' found 4
Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is ...
ELISpot kit for human Granzyme B. Kits contain PVDF plates, capture & detection antibodies, streptavidin-ALP, BSA, Skimmed dry milk, BCIP/NTB substrate, and wash buffer...
1 unit is sufficient for 1 caspase activity assay....
Anti-Rat KAPPA/LAMBDA:HRP, Clone MARK-1/MARL-15, Monoclonal Antibody...
Biology Products: